Molecular Diagnostics - Global Strategic Business Report
- Language: English
- 572 Pages
- Published: November 2012
- Region: World
Having displayed decelerating growth rates in the years 2005-2009 the US pharmaceuticals market is expected to rise quite vigorously in 2010, followed by the period of fluctuating growth in the years up to 2014.
The US pharmaceuticals market generated total revenues of $276,681.9 million in 2009, representing a compound annual growth rate (CAGR) of 2.8% for the period spanning 2005-2009. In comparison, the European and Asia-Pacific markets grew with CAGRs of 4.1% and 6.3% respectively, over the same period, to reach respective values of $187,306.7 million and $124,319.9 million in 2009.
Central nervous system sales proved the most lucrative for the US pharmaceuticals market in 2009, generating total revenues of $65,412.2 million, equivalent to 23.6% of the market's overall value. In comparison, sales of cardiovascular generated revenues of $57,132.7 million in 2009, equating to 20.6% of the market's aggregate revenues.
This report highlights the United States pharmaceutical sector in terms of market share, key trends, market players and competitive scenario in the market.
Key Highlights:
- Current market scenario of United States pharmaceutical market,
READ MORE >
1 US Pharmaceuticals Market, 2010
1.1 Quick Glance at the Market
1.2 Market Scenario
2 US Pharmaceuticals Market, By Categories, 2010
3 US Pharmaceuticals Market, By Market Players, 2010
4 US Pharmaceuticals Market Outlook, 2011-2014
5 US Pharmaceuticals Market - Competitive Analysis
6 Company Profiles
6.1 Merck & Co., Inc
6.1.1 Key Financials
6.1.2 Overview
6.1.3 Segments
6.1.4 Products and Services Analysis
6.1.5 Competitor Analysis
6.1.6 SWOT Analysis
6.2 GlaxoSmithKline Plc
6.2.1 Key Financials
6.2.2 Overview
6.2.3 Subsidiaries
6.2.4 Products and Services Analysis
6.2.5 Competitor Analysis
6.2.6 SWOT Analysis
6.2.7 Investment Analysis
6.3 Pfizer Inc
6.3.1 Key Financials
6.3.2 Overview
6.3.3 Subsidiaries
6.3.4 Products and Services Analysis
6.3.5 Competitor Analysis
6.3.6 SWOT Analysis
6.4 Johnson and Johnson
6.4.1 Key Financials
6.4.2 Overview
6.4.3 Segments
6.4.4 Products and Services Analysis
6.4.5 Competitor Analysis
6.4.6 SWOT Analysis
List of Tables:
Table 1: US Pharmaceuticals Market, ($Billions) 2005-2010
Table 2: US Pharmaceuticals Market, By Categories, 2010
Table 3: US Pharmaceuticals Market, By Market Players, 2010
Table 4: US Pharmaceuticals Market Outlook, ($Billions) 2011-2014
Table 5: Merck & Co., Inc - Key Financials
Table 6: Merck & Co., Inc - Historical Stock Information
Table 7: Merck & Co. Sales, By Products, 2009
Table 8: Merck & Co. Sales, By Geography, 2009
Table 9: GlaxoSmithKline Plc - Key Financials
Table 10: GlaxoSmithKline Plc - Histroical Stock Information
Table 11: GlaxoSmithKline Plc Sales, By Geography, 2009
Table 12: GlaxoSmithKline Plc Sales, By Products and Services, 2009
Table 13: GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2010
Table 14: GlaxoSmithKline plc, Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2010
Table 15: GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2010
Table 16: GlaxoSmithKline plc, Pharmaceuticals & Healthcare, Deals By Sector, 2005 to YTD 2010
Table 17: Pfizer Inc - Key Financials, 2007-09
Table 18: Pfizer Inc - Historical Stock Information
Table 19: Pfizer Inc Sales, By Products and Services, 2009
Table 20: Pfizer Inc Sales, By Geography, 2009
Table 21: Johnson and Johnson - Key Financials
Table 22: Johnson and Johnson -Historical Stock Information
Table 23: Johnson and Johnson - Sales, By Products and Services
Table 24: Johnson and Johnson Sales, By Geography
List of Figures:
Figure 1: US Pharmaceuticals Market, ($Billions) 2005-2010
Figure 2: US Pharmaceuticals Market, By Categories, 2010
Figure 3: US Pharmaceuticals Market, By Market Players, 2010
Figure 4: US Pharmaceuticals Market Outlook, ($Billions) 2011-2014
GlaxoSmithKline Inc
Pfizer Inc
Johnson and Johnson
Merck & Co., Inc
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| CD ROM | The report will be shipped to you in CD ROM format. | |
| Hard Copy | A printed copy of the report will be shipped to you. |